{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T18:02:51Z","timestamp":1776276171676,"version":"3.50.1"},"reference-count":127,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmn.com","cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Molecular Medicine"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1016\/j.molmed.2022.04.006","type":"journal-article","created":{"date-parts":[[2022,5,12]],"date-time":"2022-05-12T09:16:44Z","timestamp":1652347004000},"page":"569-582","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["IL-33\u2013ILC2 axis in the female reproductive tract"],"prefix":"10.1016","volume":"28","author":[{"given":"Jessica E.","family":"Miller","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Madhuri","family":"Koti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9062-050X","authenticated-orcid":false,"given":"Chandrakant","family":"Tayade","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.molmed.2022.04.006_bb0005","doi-asserted-by":"crossref","DOI":"10.4110\/in.2022.22.e11","article-title":"Targeting the epithelium-derived innate cytokines: from bench to bedside","volume":"22","author":"Ham","year":"2022","journal-title":"Immune Netw."},{"key":"10.1016\/j.molmed.2022.04.006_bb0010","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.3389\/fimmu.2019.02387","article-title":"Uterine immunity and microbiota: a shifting paradigm","volume":"10","author":"Agostinis","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.molmed.2022.04.006_bb0015","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.it.2018.01.007","article-title":"Immunology of the uterine and vaginal mucosae","volume":"39","author":"Zhou","year":"2018","journal-title":"Trends Immunol."},{"key":"10.1016\/j.molmed.2022.04.006_bb0020","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.aan2946","article-title":"An immune clock of human pregnancy","volume":"2","author":"Aghaeepour","year":"2017","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.molmed.2022.04.006_bb0025","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.aat6114","article-title":"Immune responses at the maternal\u2013fetal interface","volume":"4","author":"Ander","year":"2019","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.molmed.2022.04.006_bb0030","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/s41586-018-0698-6","article-title":"Single-cell reconstruction of the early maternal\u2013fetal interface in humans","volume":"563","author":"Vento-Tormo","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.molmed.2022.04.006_bb0035","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.immuni.2015.07.007","article-title":"Barrier epithelial cells and the control of type 2 immunity","volume":"43","author":"Hammad","year":"2015","journal-title":"Immunity"},{"key":"10.1016\/j.molmed.2022.04.006_bb0040","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1172\/JCI124606","article-title":"Epithelial cell-derived cytokines: more than just signaling the alarm","volume":"129","author":"Roan","year":"2019","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.molmed.2022.04.006_bb0045","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1038\/s41586-020-2015-4","article-title":"ILC2s amplify PD-1 blockade by activating tissue-specific cancer immunity","volume":"579","author":"Moral","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.molmed.2022.04.006_bb0050","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0002-9440(10)63631-0","article-title":"Molecular characterization of NF-HEV, a nuclear factor preferentially expressed in human high endothelial venules","volume":"163","author":"Baekkevold","year":"2003","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.molmed.2022.04.006_bb0055","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.immuni.2005.09.015","article-title":"IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines","volume":"23","author":"Schmitz","year":"2005","journal-title":"Immunity"},{"key":"10.1016\/j.molmed.2022.04.006_bb0060","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.coi.2014.09.004","article-title":"IL-33: an alarmin cytokine with crucial roles in innate immunity, inflammation and allergy","volume":"31","author":"Cayrol","year":"2014","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.molmed.2022.04.006_bb0065","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1038\/ni.3370","article-title":"Interleukin 33 is a guardian of barriers and a local alarmin","volume":"17","author":"Martin","year":"2016","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.molmed.2022.04.006_bb0070","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0003331","article-title":"The IL-1-like cytokine IL-33 is constitutively expressed in the nucleus of endothelial cells and epithelial cells in vivo: a novel \u2018alarmin\u2019?","volume":"3","author":"Moussion","year":"2008","journal-title":"PLoS ONE"},{"key":"10.1016\/j.molmed.2022.04.006_bb0075","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/j.immuni.2015.06.006","article-title":"Interleukin-33 in tissue homeostasis, injury and inflammation","volume":"42","author":"Molofsky","year":"2015","journal-title":"Immunity"},{"key":"10.1016\/j.molmed.2022.04.006_bb0080","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/nri.2016.95","article-title":"Interleukin-33 in health and disease","volume":"16","author":"Liew","year":"2016","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.molmed.2022.04.006_bb0085","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1073\/pnas.1115884109","article-title":"IL-33 is processed into mature bioactive forms by neutrophil elastase and cathepsin G","volume":"109","author":"Lefran\u00e7ais","year":"2012","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.molmed.2022.04.006_bb0090","doi-asserted-by":"crossref","first-page":"15502","DOI":"10.1073\/pnas.1410700111","article-title":"Central domain of IL-33 is cleaved by mast cell proteases for potent activation of group-2 innate lymphoid cells","volume":"111","author":"Lefran\u00e7ais","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.molmed.2022.04.006_bb0095","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/s41590-018-0067-5","article-title":"Environmental allergens induce allergic inflammation through proteolytic maturation of IL-33","volume":"19","author":"Cayrol","year":"2018","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.molmed.2022.04.006_bb0100","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1111\/imr.12619","article-title":"Interleukin-33 (IL-33): a nuclear cytokine from the IL-1 family","volume":"281","author":"Cayrol","year":"2018","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.molmed.2022.04.006_bb0105","doi-asserted-by":"crossref","first-page":"107","DOI":"10.3390\/cells11010107","article-title":"IL-33, an alarmin of the IL-1 family Involved in allergic and non allergic inflammation: focus on the mechanisms of regulation of its activity","volume":"11","author":"Cayrol","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.molmed.2022.04.006_bb0110","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abc6259","article-title":"Cellular context of IL-33 expression dictates impact on anti-helminth immunity","volume":"5","author":"Hung","year":"2020","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.molmed.2022.04.006_bb0115","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1016\/j.cmet.2021.08.004","article-title":"IL-33 causes thermogenic failure in aging by expanding dysfunctional adipose ILC2","volume":"33","author":"Goldberg","year":"2021","journal-title":"Cell Metab."},{"key":"10.1016\/j.molmed.2022.04.006_bb0120","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1016\/j.str.2009.08.009","article-title":"Structure of IL-33 and its interaction with the ST2 and IL-1RAcP receptors \u2013 insight into heterotrimeric IL-1 signaling complexes","volume":"17","author":"Lingel","year":"2009","journal-title":"Structure"},{"key":"10.1016\/j.molmed.2022.04.006_bb0125","doi-asserted-by":"crossref","first-page":"475","DOI":"10.3389\/fimmu.2017.00475","article-title":"The ST2\/IL-33 axis in immune cells during inflammatory diseases","volume":"8","author":"Griesenauer","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.molmed.2022.04.006_bb0130","doi-asserted-by":"crossref","first-page":"E7572","DOI":"10.1073\/pnas.1606608113","article-title":"IL-33\/ST2 signaling excites sensory neurons and mediates itch response in a mouse model of poison ivy contact allergy","volume":"113","author":"Liu","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.molmed.2022.04.006_bb0135","doi-asserted-by":"crossref","first-page":"2961","DOI":"10.1161\/01.CIR.0000038705.69871.D9","article-title":"Expression and regulation of ST2, an interleukin-1 receptor family member, in cardiomyocytes and myocardial infarction","volume":"106","author":"Weinberg","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.molmed.2022.04.006_bb0140","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaf1938","article-title":"Combinatorial targeting of TSLP, IL-25, and IL-33 in type 2 cytokine\u2013driven inflammation and fibrosis","volume":"8","author":"Vannella","year":"2016","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.molmed.2022.04.006_bb0145","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1016\/j.immuni.2017.10.015","article-title":"Interleukin-33-activated islet-resident innate lymphoid cells promote insulin secretion through myeloid cell retinoic acid production","volume":"47","author":"Dalmas","year":"2017","journal-title":"Immunity"},{"key":"10.1016\/j.molmed.2022.04.006_bb0150","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1038\/nature13577","article-title":"The alarmin IL-33 promotes regulatory T-cell function in the intestine","volume":"513","author":"Schiering","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.molmed.2022.04.006_bb0155","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1009121","article-title":"IL-33 facilitates rapid expulsion of the parasitic nematode Strongyloides ratti from the intestine via ILC2- and IL-9-driven mast cell activation","volume":"16","author":"Meiners","year":"2020","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.molmed.2022.04.006_bb0160","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.immuni.2013.07.018","article-title":"Interleukin-33-dependent innate lymphoid cells mediate hepatic fibrosis","volume":"39","author":"McHedlidze","year":"2013","journal-title":"Immunity"},{"key":"10.1016\/j.molmed.2022.04.006_bb0165","doi-asserted-by":"crossref","first-page":"3300","DOI":"10.1172\/JCI86881","article-title":"Stromal cell cadherin-11 regulates adipose tissue inflammation and diabetes","volume":"127","author":"Chang","year":"2017","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.molmed.2022.04.006_bb0170","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.immuni.2015.05.019","article-title":"Interleukin-33 and interferon-\u03b3 counter-regulate group 2 innate lymphoid cell activation during immune perturbation","volume":"43","author":"Molofsky","year":"2015","journal-title":"Immunity"},{"key":"10.1016\/j.molmed.2022.04.006_bb0175","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20190915","article-title":"Activation of group 2 innate lymphoid cells alleviates aging-associated cognitive decline","volume":"217","author":"Fung","year":"2020","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.molmed.2022.04.006_bb0180","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.immuni.2015.02.011","article-title":"Cigarette smoke silences innate lymphoid cell function and facilitates an exacerbated type I interleukin-33-dependent response to infection","volume":"42","author":"Kearley","year":"2015","journal-title":"Immunity"},{"key":"10.1016\/j.molmed.2022.04.006_bb0185","doi-asserted-by":"crossref","first-page":"6115","DOI":"10.1038\/s41467-021-26347-z","article-title":"Asthma-associated genetic variants induce IL33 differential expression through an enhancer-blocking regulatory region","volume":"12","author":"Aneas","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.molmed.2022.04.006_bb0190","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/S2213-2600(19)30055-4","article-title":"Shared and distinct genetic risk factors for childhood-onset and adult-onset asthma: genome-wide and transcriptome-wide studies","volume":"7","author":"Pividori","year":"2019","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.molmed.2022.04.006_bb0195","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1038\/s41590-020-0745-y","article-title":"ILC2-driven innate immune checkpoint mechanism antagonizes NK cell antimetastatic function in the lung","volume":"21","author":"Schuijs","year":"2020","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.molmed.2022.04.006_bb0200","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1002\/JLB.3A0120-379RR","article-title":"IL-33 promotes type 1 cytokine expression via p38 MAPK in human NK cells","volume":"107","author":"Ochayon","year":"2020","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.molmed.2022.04.006_bb0205","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1038\/s41590-020-0785-3","article-title":"Interleukin-33 activates regulatory T cells to suppress innate \u03b3\u03b4 T cell responses in the lung","volume":"21","author":"Faustino","year":"2020","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.molmed.2022.04.006_bb0210","doi-asserted-by":"crossref","first-page":"2998","DOI":"10.1016\/j.celrep.2019.10.120","article-title":"IL-33 signaling alters regulatory T cell diversity in support of tumor development","volume":"29","author":"Li","year":"2019","journal-title":"Cell Rep."},{"key":"10.1016\/j.molmed.2022.04.006_bb0215","doi-asserted-by":"crossref","first-page":"3117","DOI":"10.1182\/blood-2009-02-203372","article-title":"Interleukin-33 induces angiogenesis and vascular permeability through ST2\/TRAF6-mediated endothelial nitric oxide production","volume":"114","author":"Choi","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.molmed.2022.04.006_bb0220","doi-asserted-by":"crossref","first-page":"11385","DOI":"10.1038\/ncomms11385","article-title":"The PDGF-BB\u2013SOX7 axis-modulated IL-33 in pericytes and stromal cells promotes metastasis through tumour-associated macrophages","volume":"7","author":"Yang","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.molmed.2022.04.006_bb0225","doi-asserted-by":"crossref","first-page":"10602","DOI":"10.1038\/s41598-017-10894-x","article-title":"Interleukin-33 promotes inflammation-induced lymphangiogenesis via ST2\/TRAF6-mediated Akt\/eNOS\/NO signalling pathway","volume":"7","author":"Han","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.molmed.2022.04.006_bb0230","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.jhep.2017.09.010","article-title":"IL-33 exacerbates liver sterile inflammation by amplifying neutrophil extracellular trap formation","volume":"68","author":"Yazdani","year":"2018","journal-title":"J. Hepatol."},{"key":"10.1016\/j.molmed.2022.04.006_bb0235","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1038\/s41467-019-10676-1","article-title":"IL-33-mediated mast cell activation promotes gastric cancer through macrophage mobilization","volume":"10","author":"Eissmann","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.molmed.2022.04.006_bb0240","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.jaut.2014.01.032","article-title":"IL-10-producing regulatory B cells induced by IL-33 (Breg(IL-33)) effectively attenuate mucosal inflammatory responses in the gut","volume":"50","author":"Sattler","year":"2014","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.molmed.2022.04.006_bb0245","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.4049\/jimmunol.1700216","article-title":"The innate cytokines IL-25, IL-33 and TSLP cooperate in the induction of ILC2 expansion and mucous metaplasia in rhinovirus-infected immature mice","volume":"199","author":"Han","year":"2017","journal-title":"J. Immunol."},{"key":"10.1016\/j.molmed.2022.04.006_bb0250","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/nri3365","article-title":"Innate lymphoid cells-a proposal for uniform nomenclature","volume":"13","author":"Spits","year":"2013","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.molmed.2022.04.006_bb0255","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1016\/j.immuni.2019.04.019","article-title":"Tissue-resident group 2 innate lymphoid cells differentiate by layered ontogeny and in situ perinatal priming","volume":"50","author":"Schneider","year":"2019","journal-title":"Immunity"},{"key":"10.1016\/j.molmed.2022.04.006_bb0260","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1038\/s41577-020-0282-9","article-title":"Plasticity of innate lymphoid cell subsets","volume":"20","author":"Bal","year":"2020","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.molmed.2022.04.006_bb0265","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1038\/ni.3094","article-title":"Transcriptional programs define molecular characteristics of innate lymphoid cell classes and subsets","volume":"16","author":"Robinette","year":"2015","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.molmed.2022.04.006_bb0270","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1038\/s41590-018-0201-4","article-title":"Tissue signals imprint ILC2 identity with anticipatory function","volume":"19","author":"Ricardo-Gonzalez","year":"2018","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.molmed.2022.04.006_bb0275","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1038\/nature24029","article-title":"The neuropeptide NMU amplifies ILC2-driven allergic lung inflammation","volume":"549","author":"Wallrapp","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.molmed.2022.04.006_bb0280","doi-asserted-by":"crossref","first-page":"13202","DOI":"10.1038\/ncomms13202","article-title":"Nicotinic acetylcholine receptor agonist attenuates ILC2-dependent airway hyperreactivity","volume":"7","author":"Galle-Treger","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.molmed.2022.04.006_bb0285","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/imm.13138","article-title":"The interaction of intestinal microbiota and innate lymphoid cells in health and disease throughout life","volume":"159","author":"Ganal-Vonarburg","year":"2020","journal-title":"Immunology"},{"key":"10.1016\/j.molmed.2022.04.006_bb0290","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.immuni.2020.03.002","article-title":"Bacteria-induced group 2 innate lymphoid cells in the stomach provide immune protection through induction of IgA","volume":"52","author":"Satoh-Takayama","year":"2020","journal-title":"Immunity"},{"key":"10.1016\/j.molmed.2022.04.006_bb0295","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1111\/all.14491","article-title":"Estrogen receptor-\u03b1 signaling increases allergen-induced IL-33 release and airway inflammation","volume":"76","author":"Cephus","year":"2021","journal-title":"Allergy"},{"key":"10.1016\/j.molmed.2022.04.006_bb0300","doi-asserted-by":"crossref","first-page":"229","DOI":"10.4049\/jimmunol.1602085","article-title":"IL-33-responsive group 2 innate lymphoid cells are regulated by female sex hormones in the uterus","volume":"200","author":"Bartemes","year":"2018","journal-title":"J. Immunol."},{"key":"10.1016\/j.molmed.2022.04.006_bb0305","doi-asserted-by":"crossref","first-page":"3488","DOI":"10.4049\/jimmunol.1101977","article-title":"Endogenous IL-33 is highly expressed in mouse epithelial barrier tissues, lymphoid organs, brain, embryos, and inflamed tissues: in situ analysis using a novel IL-33\u2013LacZ gene trap reporter strain","volume":"188","author":"Pichery","year":"2012","journal-title":"J. Immunol."},{"key":"10.1016\/j.molmed.2022.04.006_bb0310","doi-asserted-by":"crossref","first-page":"E762","DOI":"10.1073\/pnas.1518589113","article-title":"Dysbiosis-induced IL-33 contributes to impaired antiviral immunity in the genital mucosa","volume":"113","author":"Oh","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.molmed.2022.04.006_bb0315","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.chom.2021.02.004","article-title":"Il4ra-independent vaginal eosinophil accumulation following helminth infection exacerbates epithelial ulcerative pathology of HSV-2 infection","volume":"29","author":"Chetty","year":"2021","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.molmed.2022.04.006_bb0320","doi-asserted-by":"crossref","first-page":"3057","DOI":"10.3389\/fimmu.2020.577516","article-title":"Impact of helminth infections on female reproductive health and associated diseases","volume":"11","author":"Chetty","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.molmed.2022.04.006_bb0325","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1126\/science.aac7902","article-title":"Helminth infection, fecundity, and age of first pregnancy in women","volume":"350","author":"Blackwell","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.molmed.2022.04.006_bb0330","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1084\/jem.20160880","article-title":"Inflammatory monocytes require type I interferon receptor signaling to activate NK cells via IL-18 during a mucosal viral infection","volume":"214","author":"Lee","year":"2017","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.molmed.2022.04.006_bb0335","doi-asserted-by":"crossref","first-page":"3704","DOI":"10.1128\/JVI.02626-06","article-title":"Susceptibility of CCR5-deficient mice to genital herpes simplex virus type 2 is linked to NK cell mobilization","volume":"81","author":"Thapa","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.molmed.2022.04.006_bb0340","doi-asserted-by":"crossref","first-page":"3814","DOI":"10.1210\/en.2006-1692","article-title":"Gene expression analysis of endometrium reveals progesterone resistance and candidate susceptibility genes in women with endometriosis","volume":"148","author":"Burney","year":"2007","journal-title":"Endocrinology"},{"key":"10.1016\/j.molmed.2022.04.006_bb0345","doi-asserted-by":"crossref","first-page":"17903","DOI":"10.1038\/s41598-017-18224-x","article-title":"Interleukin-33 modulates inflammation in endometriosis","volume":"7","author":"Miller","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.molmed.2022.04.006_bb0350","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1369\/0022155420911049","article-title":"Dynamic expression of interleukin-33 and ST2 in the mouse reproductive tract is influenced by superovulation","volume":"68","author":"Begum","year":"2020","journal-title":"J. Histochem. Cytochem."},{"key":"10.1016\/j.molmed.2022.04.006_bb0355","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0052252","article-title":"Disordered IL-33\/ST2 activation in decidualizing stromal cells prolongs uterine receptivity in women with recurrent pregnancy loss","volume":"7","author":"Salker","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.molmed.2022.04.006_bb0360","doi-asserted-by":"crossref","first-page":"161","DOI":"10.4049\/jimmunol.1400381","article-title":"Unique temporal and spatial expression patterns of IL-33 in ovaries during ovulation and estrous cycle are associated with ovarian tissue homeostasis","volume":"193","author":"Carlock","year":"2014","journal-title":"J. Immunol."},{"key":"10.1016\/j.molmed.2022.04.006_bb0365","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.4049\/jimmunol.1402503","article-title":"IL-33 is required for disposal of unnecessary cells during ovarian atresia through regulation of autophagy and macrophage migration","volume":"194","author":"Wu","year":"2015","journal-title":"J. Immunol."},{"key":"10.1016\/j.molmed.2022.04.006_bb0370","doi-asserted-by":"crossref","first-page":"3734","DOI":"10.4049\/jimmunol.1300490","article-title":"Macrophage-derived IL-33 is a critical factor for placental growth","volume":"191","author":"Fock","year":"2013","journal-title":"J. Immunol."},{"key":"10.1016\/j.molmed.2022.04.006_bb0375","doi-asserted-by":"crossref","first-page":"327","DOI":"10.3109\/14767058.2012.735724","article-title":"Interleukin-33 in the human placenta","volume":"26","author":"Topping","year":"2013","journal-title":"J. Matern. Fetal Neonatal Med."},{"key":"10.1016\/j.molmed.2022.04.006_bb0380","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.jri.2015.01.004","article-title":"Decidual stromal cell-derived IL-33 contributes to Th2 bias and inhibits decidual NK cell cytotoxicity through NF-\u03baB signaling in human early pregnancy","volume":"109","author":"Hu","year":"2015","journal-title":"J. Reprod. Immunol."},{"key":"10.1016\/j.molmed.2022.04.006_bb0385","doi-asserted-by":"crossref","first-page":"960","DOI":"10.3389\/fimmu.2019.00960","article-title":"Uterine natural killer cells","volume":"10","author":"Sojka","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.molmed.2022.04.006_bb0390","doi-asserted-by":"crossref","first-page":"2396","DOI":"10.3389\/fimmu.2018.02396","article-title":"Innate lymphoid cells in the maternal and fetal compartments","volume":"9","author":"Miller","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.molmed.2022.04.006_bb0395","doi-asserted-by":"crossref","first-page":"3937","DOI":"10.4049\/jimmunol.1500689","article-title":"Composition, development, and function of uterine innate lymphoid cells","volume":"195","author":"Doisne","year":"2015","journal-title":"J. Immunol."},{"key":"10.1016\/j.molmed.2022.04.006_bb0400","doi-asserted-by":"crossref","DOI":"10.1111\/aji.13502","article-title":"Reduced innate lymphoid cells in the endometrium of women with endometriosis","volume":"87","author":"Sugahara","year":"2022","journal-title":"Am. J. Reprod. Immunol."},{"key":"10.1016\/j.molmed.2022.04.006_bb0405","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3389\/fimmu.2016.00043","article-title":"The residual innate lymphoid cells in NFIL3-deficient mice support suboptimal maternal adaptations to pregnancy","volume":"7","author":"Boulenouar","year":"2016","journal-title":"Front. Immunol."},{"key":"10.1016\/j.molmed.2022.04.006_bb0410","article-title":"Maternal group 2 innate lymphoid cells control fetal growth and protect from endotoxin-induced abortion in mice","author":"Balmas","year":"2018","journal-title":"BioRxiv"},{"key":"10.1016\/j.molmed.2022.04.006_bb0415","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1038\/mi.2014.63","article-title":"Identification of diverse innate lymphoid cells in human decidua","volume":"8","author":"Vacca","year":"2015","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.molmed.2022.04.006_bb0420","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.jri.2017.09.003","article-title":"Molecular signature and functional analysis of uterine ILCs in mouse pregnancy","volume":"123","author":"Li","year":"2017","journal-title":"J. Reprod. Immunol."},{"key":"10.1016\/j.molmed.2022.04.006_bb0425","doi-asserted-by":"crossref","DOI":"10.1111\/aji.12820","article-title":"Innate lymphoid cells at the human maternal\u2013fetal interface in spontaneous preterm labor","volume":"79","author":"Xu","year":"2018","journal-title":"Am. J. Reprod. Immunol."},{"key":"10.1016\/j.molmed.2022.04.006_bb0430","doi-asserted-by":"crossref","first-page":"504","DOI":"10.3892\/ol.2021.12765","article-title":"Role of the IL-33\/ST2 receptor axis in ovarian cancer progression","volume":"22","author":"Liu","year":"2021","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.molmed.2022.04.006_bb0435","first-page":"1045","article-title":"Association between interleukin-33 and ovarian cancer","volume":"41","author":"Liu","year":"2019","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.molmed.2022.04.006_bb0440","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1016\/S0140-6736(21)00682-6","article-title":"Miscarriage matters: the epidemiological, physical, psychological, and economic costs of early pregnancy loss","volume":"397","author":"Quenby","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.molmed.2022.04.006_bb0445","doi-asserted-by":"crossref","first-page":"23806","DOI":"10.1038\/srep23806","article-title":"Genetic variant in IL-33 is associated with idiopathic recurrent miscarriage in Chinese Han population","volume":"6","author":"Yue","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.molmed.2022.04.006_bb0450","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1080\/09513590.2018.1528220","article-title":"Association of IL-10, IL-18, and IL-33 genetic polymorphisms with recurrent pregnancy loss risk in Iranian women","volume":"35","author":"Soheilyfar","year":"2019","journal-title":"Gynecol. Endocrinol."},{"key":"10.1016\/j.molmed.2022.04.006_bb0455","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.cyto.2018.03.025","article-title":"The association of IL-33 and Foxp3 gene polymorphisms with recurrent pregnancy loss in Egyptian women","volume":"108","author":"Zidan","year":"2018","journal-title":"Cytokine"},{"key":"10.1016\/j.molmed.2022.04.006_bb0460","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.3389\/fphys.2021.789829","article-title":"IL-33 and soluble ST2 are associated with recurrent spontaneous abortion in early pregnancy","volume":"12","author":"Zhao","year":"2022","journal-title":"Front. Physiol."},{"key":"10.1016\/j.molmed.2022.04.006_bb0465","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/nm.4244","article-title":"Interleukin-33-induced expression of PIBF1 by decidual B cells protects against preterm labor","volume":"23","author":"Huang","year":"2016","journal-title":"Nat. Med."},{"key":"10.1016\/j.molmed.2022.04.006_bb0470","doi-asserted-by":"crossref","first-page":"111","DOI":"10.3109\/14767058.2013.806894","article-title":"Soluble ST2, a modulator of the inflammatory response, in preterm and term labor","volume":"27","author":"Stampalija","year":"2014","journal-title":"J. Matern. Fetal Neonatal Med."},{"key":"10.1016\/j.molmed.2022.04.006_bb0475","doi-asserted-by":"crossref","first-page":"446","DOI":"10.3389\/fimmu.2020.00446","article-title":"Expression of IL-33 receptor is significantly up-regulated in B cells during pregnancy and in the acute phase of preterm birth in mice","volume":"11","author":"Valeff","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.molmed.2022.04.006_bb0480","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/1471-0528.12629","article-title":"Pre-eclampsia, eclampsia and adverse maternal and perinatal outcomes: a secondary analysis of the World Health Organization Multicountry Survey on Maternal and Newborn Health","volume":"121","author":"Abalos","year":"2014","journal-title":"BJOG"},{"key":"10.1016\/j.molmed.2022.04.006_bb0485","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.3389\/fimmu.2020.01864","article-title":"Mechanisms of key innate immune cells in early- and late-onset preeclampsia","volume":"11","author":"Aneman","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.molmed.2022.04.006_bb0490","doi-asserted-by":"crossref","first-page":"3942","DOI":"10.1080\/14767058.2019.1593359","article-title":"Maternal and fetal leptin and interleukin 33 concentrations in pregnancy complicated by obesity and preeclampsia","volume":"33","author":"Beneventi","year":"2020","journal-title":"J. Matern. Fetal Neonatal Med."},{"key":"10.1016\/j.molmed.2022.04.006_bb0495","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1080\/10641955.2017.1302470","article-title":"Decreased frequency of peripheral blood CD8+CD25+FoxP3+ regulatory T cells correlates with IL-33 levels in pre-eclampsia","volume":"36","author":"Yu","year":"2017","journal-title":"Hypertens. Pregnancy"},{"key":"10.1016\/j.molmed.2022.04.006_bb0500","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/9787239","article-title":"Decreased IL-33 production contributes to trophoblast cell dysfunction in pregnancies with preeclampsia","volume":"2018","author":"Chen","year":"2018","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.molmed.2022.04.006_bb0505","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0024463","article-title":"ST2 and IL-33 in pregnancy and pre-eclampsia","volume":"6","author":"Granne","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.molmed.2022.04.006_bb0510","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/j.molmed.2018.07.004","article-title":"The immunopathophysiology of endometriosis","volume":"24","author":"Symons","year":"2018","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.molmed.2022.04.006_bb0515","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1093\/humrep\/des154","article-title":"Serum and peritoneal interleukin-33 levels are elevated in deeply infiltrating endometriosis","volume":"27","author":"Santulli","year":"2012","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.molmed.2022.04.006_bb0520","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.imlet.2015.05.002","article-title":"Soluble ST2 and IL-33: potential markers of endometriosis in the Tunisian population","volume":"166","author":"Mbarik","year":"2015","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.molmed.2022.04.006_bb0525","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.149699","article-title":"Interleukin-33 activates group 2 innate lymphoid cell expansion and modulates endometriosis","volume":"6","author":"Miller","year":"2021","journal-title":"JCI Insight"},{"key":"10.1016\/j.molmed.2022.04.006_bb0530","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.3389\/fimmu.2019.02021","article-title":"Interleukin-1\/-33 signaling pathways as therapeutic targets for endometriosis","volume":"10","author":"Kato","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.molmed.2022.04.006_bb0535","doi-asserted-by":"crossref","first-page":"3192","DOI":"10.1080\/14767058.2019.1679766","article-title":"Increased levels of serum IL-33 is associated with adverse maternal outcomes in placenta previa accreta","volume":"34","author":"Ozler","year":"2019","journal-title":"J. Matern. Fetal Neonatal Med."},{"key":"10.1016\/j.molmed.2022.04.006_bb0540","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1007\/s40618-016-0472-2","article-title":"Clinical significance of ADAMTS1, ADAMTS5, ADAMTS9 aggrecanases and IL-17A, IL-23, IL-33 cytokines in polycystic ovary syndrome","volume":"39","author":"Karakose","year":"2016","journal-title":"J. Endocrinol. Investig."},{"key":"10.1016\/j.molmed.2022.04.006_bb0545","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1093\/humrep\/det238","article-title":"Profibrotic interleukin-33 is correlated with uterine leiomyoma tumour burden","volume":"28","author":"Santulli","year":"2013","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.molmed.2022.04.006_bb0550","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1177\/1933719118816852","article-title":"The disease phenotype of adenomyosis-affected women correlates with specific serum cytokine profiles","volume":"26","author":"Bourdon","year":"2019","journal-title":"Reprod. Sci."},{"key":"10.1016\/j.molmed.2022.04.006_bb0555","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s12032-014-0143-0","article-title":"Examining IL-33 expression in the cervix of HPV-infected patients: a preliminary study comparing IL-33 levels in different stages of disease and analyzing its potential association with IFN-\u03b3","volume":"31","author":"Wang","year":"2014","journal-title":"Med. Oncol."},{"key":"10.1016\/j.molmed.2022.04.006_bb0560","doi-asserted-by":"crossref","first-page":"2850","DOI":"10.3389\/fimmu.2018.02850","article-title":"Increased expression of sST2 in early HIV infected patients attenuated the IL-33 induced T cell responses","volume":"9","author":"Wu","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.molmed.2022.04.006_bb0565","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1111\/1346-8138.14334","article-title":"Interleukin-33 is expressed in the lesional epidermis in herpes virus infection but not in verruca vulgaris","volume":"45","author":"Jin","year":"2018","journal-title":"J. Dermatol."},{"key":"10.1016\/j.molmed.2022.04.006_bb0570","doi-asserted-by":"crossref","first-page":"2170","DOI":"10.1038\/jid.2013.150","article-title":"Mast cells play a key role in host defense against herpes simplex virus infection through TNF-\u03b1 and IL-6 production","volume":"133","author":"Aoki","year":"2013","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.molmed.2022.04.006_bb0575","doi-asserted-by":"crossref","first-page":"E1520","DOI":"10.1073\/pnas.1710401115","article-title":"Male-specific IL-33 expression regulates sex-dimorphic EAE susceptibility","volume":"115","author":"Russi","year":"2018","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.molmed.2022.04.006_bb0580","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.molimm.2020.09.019","article-title":"Sex differences in group 2 innate lymphoid cell-dominant allergic airway inflammation","volume":"128","author":"Wang","year":"2020","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.molmed.2022.04.006_bb0585","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1084\/jem.20161807","article-title":"Androgen signaling negatively controls group 2 innate lymphoid cells","volume":"214","author":"Laffont","year":"2017","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.molmed.2022.04.006_bb0590","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.1016\/j.celrep.2017.10.110","article-title":"Testosterone attenuates group 2 innate lymphoid cell-mediated airway inflammation","volume":"21","author":"Cephus","year":"2017","journal-title":"Cell Rep."},{"key":"10.1016\/j.molmed.2022.04.006_bb0595","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.jaci.2021.04.029","article-title":"Targeting androgen signaling in ILC2s protects from IL-33-driven lung inflammation, independently of KLRG1","volume":"149","author":"Blanquart","year":"2022","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.molmed.2022.04.006_bb0600","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.immuni.2019.02.002","article-title":"Adventitial stromal cells define group 2 innate lymphoid cell tissue niches","volume":"50","author":"Dahlgren","year":"2019","journal-title":"Immunity"},{"key":"10.1016\/j.molmed.2022.04.006_bb0605","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/nature12526","article-title":"Type 2 innate lymphoid cells control eosinophil homeostasis","volume":"502","author":"Nussbaum","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.molmed.2022.04.006_bb0610","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1038\/nrd2660","article-title":"The IL-33\/ST2 pathway: therapeutic target and novel biomarker","volume":"7","author":"Kakkar","year":"2008","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.molmed.2022.04.006_bb0615","first-page":"2764","article-title":"IL-33 drives expansion of type 2 innate lymphoid cells and regulatory T cells and protects mice from severe, acute colitis","volume":"12","author":"Phuong","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.molmed.2022.04.006_bb0620","doi-asserted-by":"crossref","first-page":"4219","DOI":"10.1038\/s41598-017-03674-0","article-title":"Interleukin 33 exacerbates antigen driven airway hyperresponsiveness, inflammation and remodeling in a mouse model of asthma","volume":"7","author":"Sj\u00f6berg","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.molmed.2022.04.006_bb0625","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.jaci.2019.02.028","article-title":"IL-33trap is a novel IL-33 neutralizing biologic that inhibits allergic airway inflammation","volume":"144","author":"Holgado","year":"2019","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.molmed.2022.04.006_bb0630","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1186\/s12974-020-01932-z","article-title":"Neuroprotective effect of astrocyte-derived IL-33 in neonatal hypoxic-ischemic brain injury","volume":"17","author":"Jiao","year":"2020","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.molmed.2022.04.006_bb0635","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1186\/s12967-021-03189-3","article-title":"Development of an ultra-sensitive human IL-33 biomarker assay for age-related macular degeneration and asthma drug development","volume":"19","author":"Mai","year":"2021","journal-title":"J. Transl. Med."}],"container-title":["Trends in Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471491422001022?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471491422001022?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T07:25:44Z","timestamp":1761463544000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1471491422001022"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":127,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2022,7]]}},"alternative-id":["S1471491422001022"],"URL":"https:\/\/doi.org\/10.1016\/j.molmed.2022.04.006","relation":{},"ISSN":["1471-4914"],"issn-type":[{"value":"1471-4914","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"IL-33\u2013ILC2 axis in the female reproductive tract","name":"articletitle","label":"Article Title"},{"value":"Trends in Molecular Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.molmed.2022.04.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}